The Effect of AUDIT and Feedback on Pneumococcal Vaccination Coverage
Pneumococcal Infections
About this trial
This is an interventional prevention trial for Pneumococcal Infections focused on measuring AUDIT, Feedback, general practice, pneumococcal vaccination rate
Eligibility Criteria
Inclusion Criteria To be eligible for inclusion in the study, general practice (GP) centers must conform to the following conditions: It is a Flemish GP center in the INTEGO network. The GP center uses an electronic health record (EHR), automatically linked to the INTEGO database. The physician (one per center, in name of all GPs in that center) signs a specific study consent form. To be eligible for inclusion in the study, patients must conform to the following conditions: The patient belongs to a target group for pneumococcal vaccination (based on https://www.health.belgium.be/sites/default/files/uploads/fields/fpshealth_theme_file/hgr_9562_vaccinatie_tegen_pneumokokken_vweb.pdf): A. Adults aged 16 - 85 years old with a high risk for a pneumococcal infection Adults with an immunity disorder Adults with anatomical and / or functional asplenia, sickle-cell disease or hemoglobinopathy Adults with cerebrospinal fluid or cochlear implant leakage B. Adults (aged 50 - 85 years old) with comorbidity Chronic cardiac disease Chronic pulmonary disease or smoker Chronic liver disease or ethylabusus Chronic kidney disease Chronic neurological or neuromuscular disorders with aspiration risk Diabetes mellitus C. Healthy persons aged 65 - 85 years old The patient has an electronic medical record (EMR) in the participating general practice centre. This EMR contains all the patient information, for instance regarding medical history and medication and is managed by the general practitioner. Exclusion criteria Patients excluded from feedback: patients not belonging to one of the target groups for pneumococcal vaccination. Patients excluded from AUDIT: patients not belonging to one of the target groups for pneumococcal vaccination OR Correctly vaccinated high-risk patients (PPV23 less than 5 years ago AND PCV13 ever received) Correctly vaccinated adults with comorbidity (1) PCV13 ever received AND PPV23 less than 5 years ago, OR 2) PCV13 ever received AND 2x PPV23 vaccination more than 5 years ago) Correctly vaccinated healthy persons (PPV23 ever received)
Sites / Locations
- Academic Center of General PracticeRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Intervention group
Control group
The INTEGO practices (INTEGO is a GP morbidity registry in Flanders Belgium) that will be assigned to the intervention group will receive an extended electronic feedback report with multiple components, directly implemented in their EHR (electronic health record), on the pneumococcal vaccination coverage in adults at risk in their practice ('push system'). There will be a direct connection between the EHR of the practice and a SAS visual analytics tool in the Healthdata environment (single-sign-on connection), that will show the extended feedback. This report will be available at baseline and updated every two months based on the current situation.
Every GP center assigned to the control group will only have access to the clinical AUDIT to identify patients that may benefit from a pneumococcal vaccination. GP centers in the control group will not receive an extended feedback report at baseline and every 2 months afterwards.